Taisho Pharmaceutical

Company Drug

Jiangsu Hengrui Pharmaceuticals Gets NMPA Approval for Esflurbiprofen Patch Clinical Study

Fineline Cube Jul 6, 2023

Jiangsu Hengrui Pharmaceuticals Co., Ltd (SHA: 600276), a leading pharmaceutical company based in China, has...

Company Deals

Sanofi Completes Vicebio $1.6B Acquisition, Adds RSV Vaccine Platform

Company Drug

Juventas CAR-T LBCL Launch Marks Second Indication

Company Drug

BMS Breyanzi MZL FDA Approval First CAR-T

Company Deals

Formosa Pharma APP13007 Clobetasol ASEAN Deal with Rxilient